Leukocyte Common Antigens [antigeny CD45]
- Terms
-
antigen CD45
LCA
společný leukocytární antigen
-
2H4 Antigens
Antigens, CD45
B220 Antigen
B220 Antigens
CD45 Antigen
CD45 Antigens
CD45R Antigens
CD45R0 Antigens
CD45RA Antigens
CD45RB Antigens
CD45RCAntigens
CD45RO Antigens
L-CA Antigens
Leukocyte Common Antigen
Protein Tyrosine Phosphatase, Receptor Type, C
T200 Antigens
High-molecular weight glycoproteins uniquely expressed on the surface of LEUKOCYTES and their hemopoietic progenitors. They contain two FIBRONECTIN TYPE III DOMAINS and possess cytoplasmic protein tyrosine phosphatase activity, which plays a role in intracellular signaling from the CELL SURFACE RECEPTORS. Leukocyte common antigens occur as multiple isoforms that result from alternative mRNA splicing and differential usage of three exons.
- DUI
- D017493 MeSH Browser
- CUI
- M0026536
- Previous indexing
- Antigens, CD (1989-1992); Antigens, Differentiation (1984-1991); Histocompatibility Antigens (1984-1992)
- History note
- 2018 (1993); for RT7 use HISTOCOMPATIBILITY ANTIGENS RT 1983-92; for B220 ANTIGEN use ANTIGENS, CD45 1990-95
- Public note
- 2018; see ANTIGENS, CD45 1993-2017 and CD45 ANTIGEN 1984-1992; CD45 ANTIGEN was indexed under ANTIGENS, CD 1989-92 and HISTOCOMPATIBILITY ANTIGENS & ANTIGENS, DIFFERENTIATION 1984-92; RT7 ANTIGEN was indexed under HISTOCOMPATIBILITY ANTIGENS 1983-92; B220 ANTIGEN was indexed under ANTIGENS, SURFACE 1990-95
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects 0
- AN
- analysis 3
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 0
- BL
- blood 3
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 1
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 5
- HI
- history 0
- IM
- immunology 9
- IP
- isolation & purification 0
- ME
- metabolism 16
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0